Multiple drugsTreatment failure, Kaposi sarcoma and rebound effect in the form of rheumatoid arthritis flare

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2000卷 / 1期

关键词：

D O I：

10.1007/s40278-024-54961-3

中图分类号：

学科分类号：

摘要：

引用

页码：272 / 272

共 50 条

[1] Multiple drugsTreatment failure and rebound effect in form of flare of atopic dermatitis: case report
Reactions Weekly, 2021, 1871 (1) : 303 - 303
[2] Multiple drugsTreatment ineffective and rebound effect in the form of severe flare of UC
Reactions Weekly, 2024, 1999 (1) : 273 - 273
[3] Multiple drugsTreatment failure and Kaposi sarcoma: case report
Reactions Weekly, 2022, 1889 (1) : 232 - 232
[4] Multiple drugsTreatment failure and rebound effect in the form of progression of pyoderma gangrenosum
Reactions Weekly, 2024, 1996 (1) : 168 - 168
[5] Kaposi's sarcoma complicating rheumatoid arthritis treated with corticosteroid Kaposi's sarcoma and rheumatoid arthritis
Sahin, Mehmet
Keskin, Muharrem
Tunc, Sevket E.
Coskun, Hasan S.
Kapucuoglu, Nigun
SAUDI MEDICAL JOURNAL, 2007, 28 (07) : 1133 - 1134
[6] Coexistence of Kaposi's sarcoma and rheumatoid arthritis
Demirsoy, Evren Odyakmaz
Kiran, Rebiay
Cefle, Ayse
Gokdemir, Mine
Ercin, Cengiz
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2012, 46 (04): : 213 - 216
[7] Infliximab/methotrexate/tocilizumabLymphoproliferative disorder, anaphylactic shock and rebound effect in the form of rheumatoid arthritis flare: 3 case reports
Reactions Weekly, 2023, 1946 (1) : 294 - 294
[8] Multiple drugsTreatment failure/no therapeutic response, drug intolerance and rebound effect: 7 case reports
Reactions Weekly, 2023, 1962 (1) : 306 - 306
[9] Is Tocilizumab Safe in Kaposi Sarcoma? A Complex Association Among Rheumatoid Arthritis, Psoriasis, and Kaposi Sarcoma
Verdelli, Alice
Bonciani, Diletta
Bonciolini, Veronica
Caproni, Marzia
CLINICAL DRUG INVESTIGATION, 2014, 34 (06) : 437 - 438
[10] Is Tocilizumab Safe in Kaposi Sarcoma? A Complex Association Among Rheumatoid Arthritis, Psoriasis, and Kaposi Sarcoma
Alice Verdelli
Diletta Bonciani
Veronica Bonciolini
Marzia Caproni
Clinical Drug Investigation, 2014, 34 : 437 - 438

← 1 2 3 4 5 →